Seattle-based Nohla Therapeutics, a biotech startup spun out of the Fred Hutchinson Cancer Research Center, just announced a whopping $43.5 million… Read More
Seattle-based biotech company PhaseRx develops drug candidates to treat rare, often life-threatening liver diseases, and one of their candidates just got… Read More
There are two basic models for scientific research — industry and academia — and each has its strengths. Academia can support sustained, long-term… Read More
The Seattle-based Infectious Disease Research Institute (IDRI), a product-focused nonprofit that fights infectious diseases around the world, announced today that… Read More
What does it take for a region to become truly revolutionary? Dr. Richard Klausner, co-founder and director of biotechnology company Juno Therapeutics,… Read More
Sound Pharmaceuticals, a Seattle startup developing therapies and preventative treatments for hearing loss, is in the midst of a $30 million… Read More
Bothell-based Seattle Genetics and Tokyo-based Takeda Oncology announced the success of their phase 3 clinical trial of Adcetris today, an immunotherapy drug that… Read More
The University of Washington held its first annual Health Innovation Challenge (HIC) Thursday—bringing innovators in entrepreneurship, business and health science… Read More
Chris Rivera is stepping down as president and CEO of the Washington Biotechnology & Biomedical Association, a nonprofit biotech trade group. He… Read More
